Search

Patients with inoperable advanced liver cancer have a new option for treatment to extend their lives.

… Monday, October 24, 2022 Patients with inoperable advanced liver cancer have a new option for treatment to extend their lives. Today the U.S. Food and Drug Administration (FDA) approved a combination of the immunotherapy drugs durvalumab (Imfinzi®) plus the experimental drug tremelimumab for people with

Fellowship recipient Dr. Francisco Sanchez-Vega will research factors that lead to negative colorectal cancer outcomes in Black communities.

… Thursday, April 13, 2023 Corning Incorporated and Memorial Sloan Kettering Cancer Center (MSK) announced today that Dr. Francisco Sanchez-Vega, PhD, has been awarded the Corning-MSK Health Equity Research Fellowship, a two-year grant that funds research into the broad disparities in cancer outcomes for

A phase 3 trial led by MSK showed that adding epcoritamab to traditional treatment for follicular lymphoma benefits patients. Epcoritamab received FDA approval based on the findings.

… Sunday, December 7, 2025 Retired New York City police officer Michael T. had grown used to getting bad news about the follicular lymphoma  that he had been living with for more than 20 years. “I have a relapse about every five years,” says Michael, who was a 9/11 first responder and worked at Ground

Memorial Sloan Kettering scientists, physicians, and administrators are developing and commercializing research discoveries to generate more-effective and affordable cancer treatments.

… Thursday, December 1, 2011 Summary Memorial Sloan Kettering scientists, physicians, and administrators are developing and commercializing research discoveries to generate more-effective and affordable cancer treatments. At Memorial Sloan Kettering, scientists, physicians, and administrators strive to

The common wisdom is that genes are preserved from generation to generation because they help the organism survive and reproduce. But MSK's Dr. Eric Lai’s team is showing — in fruit flies — that certain genes can threaten a species’ very survival by pursuing their narrow self-interests in passing along their own genetic material.

… Monday, August 28, 2023 Developmental biologist Eric Lai, PhD , and his lab at Memorial Sloan Kettering Cancer Center (MSK) have been studying hotbeds of biological conflict. Only instead of battles between outside invaders and internal defenders, they’ve uncovered an evolutionary battle of the sexes

To celebrate National Nurses Week (May 6 to May 12), Today Show anchor Hoda Kotb interviewed MSK Nurse Cassie DeMatteis about an extraordinary relationship with one of her littlest patients.

… Tuesday, May 10, 2022 NBC's Hoda Kotb hugs MSK Nurse Cassie DeMatteis. NBC's Hoda Kotb hugs MSK Nurse Cassie DeMatteis. MSK Nurse Cassie DeMatteis speaks to NBC's Hoda Kotb about her special relationship with a pediatric patient and his family. MSK Nurse Cassie DeMatteis speaks to NBC's Hoda Kotb about

Four MSK clinicians were accepted into a career development program aimed at increasing diverse participation in clinical trials.

… Tuesday, November 16, 2021 On October 25, 2022, the Bristol Myers Squibb Foundation announced the second cohort of this program, now known as The Robert A. Winn Diversity in Clinical Trials Award Program. Two MSK clinicians, Drs. Fiyinfolu Balogun and Joshua Budhu , are in this second cohort and will

Read about a therapeutic vaccine that could potentially prevent certain pancreatic and colorectal cancers from returning.

… Monday, August 11, 2025 According to a study co-led by researchers at Memorial Sloan Kettering Cancer Center (MSK), a new vaccine shows encouraging early results as a potential “off-the-shelf” treatment for patients with  pancreatic  or  colorectal cancer . Unlike individualized cancer vaccines, which

Lea sobre una vacuna terapéutica que podría ayudar a prevenir que ciertos casos de cáncer de páncreas y colorrectal vuelvan a aparecer.

… Monday, August 11, 2025 Según un estudio codirigido por investigadores del Memorial Sloan Kettering Cancer Center (MSK), una nueva vacuna muestra resultados iniciales prometedores como posible tratamiento ‘listo para usar’ para pacientes con cáncer de páncreas  o  colorrectal . A diferencia de las vacunas

Oncologic outcomes are similar with the use of a sentinel lymph node algorithm compared to performing a full pelvic and paraaortic lymph node dissection in node-negative patients with deeply invasive endometroid endometrial carcinoma.

… Monday, January 14, 2019 Oncologic outcomes are similar with the use of a sentinel lymph node (SLN) algorithm compared to performing a full pelvic and paraaortic lymph node dissection (LND) in node-negative patients with deeply invasive endometroid endometrial carcinoma (EEC), according to our recent